Mitralife
Records under this name other than patents Mitralife holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Mitralife
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,935,146 | Percutaneous mitral annuloplasty with hemodynamic monitoring Formerly held Term ended Term ended Oct 10, 2021 · USPTO record | Term ended | Term ended Oct 10, 2021 | USPTO record |
| US 7,988,726 | Percutaneous mitral annuloplasty with cardiac rhythm management Formerly held Term ended Term ended Dec 4, 2020 · USPTO record | Term ended | Term ended Dec 4, 2020 | USPTO record |
| US 6,709,456 | Percutaneous mitral annuloplasty with hemodynamic monitoring Formerly held Term ended Term ended Aug 21, 2020 · USPTO record | Term ended | Term ended Aug 21, 2020 | USPTO record |
| US 6,989,028 | Medical system and method for remodeling an extravascular tissue structure Formerly held Term ended Term ended Jul 11, 2020 · USPTO record | Term ended | Term ended Jul 11, 2020 | USPTO record |
| US 6,402,781 | Percutaneous mitral annuloplasty and cardiac reinforcement Formerly held Term ended Term ended Jan 31, 2020 · USPTO record | Term ended | Term ended Jan 31, 2020 | USPTO record |
| US 6,537,314 | Percutaneous mitral annuloplasty and cardiac reinforcement Formerly held Term ended Term ended Jan 31, 2020 · USPTO record | Term ended | Term ended Jan 31, 2020 | USPTO record |
| US 6,706,065 | Endoluminal ventricular retention Formerly held Term ended Term ended Jan 31, 2020 · USPTO record | Term ended | Term ended Jan 31, 2020 | USPTO record |
| US 6,810,882 | Transluminal mitral annuloplasty Formerly held Term ended Term ended Jan 31, 2020 · USPTO record | Term ended | Term ended Jan 31, 2020 | USPTO record |